Medicamen Biotech Limited

NSE: MEDICAMEQ BSE: 531146 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

286 14(5%)

Volume

Open

520

High

521

Low

506

272

VWAP

52 Week High

508

52 Week Low

217

Viand Research Rating

Quality Score

00/00

Growth Score

00/00

Valuation Score

00/00

Momentum Score

00/00

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

388

No. of Shares

1.36

P/E

53.7

P/B

2.67

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

4.97

ROCE

Profit Growth

Listing Date

27-Oct-21

Promoter Holding

40.46%

FII Holding

0.02%

DII Holding

0.44%

Price Chart

Price Performance

1 Week0

1 Month0

3 Months0

6 Months0

1 Year0

YTD0

Moving Average

5 Day SMA0

10 Day SMA0

20 Day SMA0

30 Day SMA0

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3
Resistance 2
Resistance 1
Pivot Point
Support 1
Support 2
Support 3

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	Div Yld %
1	SUNPHARMA	4,42,187	1843	2%	14%	2%	9%	39	0	0	0
2	DIVISLAB	1,80,280	6791	2%	6%	4%	1%	65	0	0	0
3	TORNTPHARM	1,53,281	4529	0%	8%	18%	40%	64	0	0	0
4	APOLLOHOSP	1,19,047	8280	3%	7%	12%	17%	58	0	0	0
5	CIPLA	1,14,869	1422	1%	10%	7%	4%	22	0	0	0
6	DRREDDY	1,11,015	1330	0%	1%	7%	7%	20	0	0	0
7	ZYDUSLIFE	1,09,378	1087	6%	16%	15%	17%	20	0	0	0
8	LUPIN	1,04,017	2275	1%	2%	9%	15%	23	0	0	0
9	MANKIND	1,00,482	2434	3%	7%	7%	2%	49	0	0	0
10	MAXHEALTH	96,867	995	7%	1%	15%	14%	0	0	0	0
Load More

Shareholding Pattern (%)

	Dec 2025	Sep 2025	Jun 2025	Apr 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 40.46%	(0.01) 40.46%	(0.01) 40.46%	(-2.71) 40.46%	(0.21) 43.16%	(0.01) 42.99%	(0.01) 42.99%	(-0.21) 42.99%	(0.01) 43.21%	(0.01) 43.21%	(0.01) 43.21%	(0.01) 43.21%	(0.01) 43.21%	(0.01) 43.21%	(-0.41) 43.21%	(0.01) 43.60%	(0.01) 43.60%	(-1.21) 43.60%	(0.01) 44.83%
FIIs	(0.01) 0.02%	(0.11) 0.05%	(-0.21) 0.00%	(0.11) 0.22%	(0.11) 0.12%	(0.01) 0.06%	(0.01) 0.06%	(-0.11) 0.06%	(-0.11) 0.12%	(0.01) 0.22%	(0.11) 0.22%	(0.01) 0.16%	(0.01) 0.19%	(-1.71) 0.17%	(1.51) 1.83%	(-0.11) 0.35%	(0.11) 0.40%	(0.01) 0.35%	(0.01) 0.35%
DIIs	(-0.21) 0.44%	(-0.11) 0.59%	(0.01) 0.64%	(0.01) 0.65%	(-0.21) 0.69%	(-0.31) 0.87%	(0.01) 1.17%	(0.21) 1.17%	(0.31) 0.99%	(0.51) 0.67%	(0.01) 0.20%	(0.01) 0.20%	(0.01) 0.20%	(0.11) 0.20%	(0.11) 0.13%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
Government	0.05%	0.05%	0.05%	0.05%	0.06%	0.06%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	59.02%	58.84%	58.83%	58.62%	55.99%	56.04%	55.79%	55.78%	55.69%	55.90%	56.38%	56.44%	56.40%	56.42%	54.84%	56.06%	56.01%	56.06%	54.82%
No. of Shareholders	10,967	11,177	10,808	10,592	10,435	10,576	10,792	10,652	10,639	10,252	9,419	8,272	8,233	8,273	8,332	9,107	9,300	9,140	5,595

Quarterly Results

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	46.91	47.17	43.04	29.61	45.14	44.74	43.05	47.32	46.5	43.54	41.94	38.67	35.58	33.53	33.09	22.75	32.64	32.52	27.53
Expenses	42.53	42.01	38.43	31.22	38.43	39.43	39.6	41.57	41.6	38.89	34.99	32.18	29.71	27.67	27.43	17.79	26.34	26.3	21.49
Operating Profit	4.38	5.16	4.61	-1.61	6.71	5.31	3.45	5.75	4.9	4.65	6.95	6.49	5.87	5.86	5.66	4.96	6.3	6.22	6.04
OPM %	9.34	10.94	10.71	-5.44	14.86	11.87	8.01	12.15	10.54	10.68	16.57	16.78	16.5	17.48	17.1	21.8	19.3	19.13	21.94
Other Income	0.53	0.37	0.47	5.23	0.14	0.29	0.59	0.57	0.83	0.55	0.38	0.35	0.63	0.52	0.96	0.34	0.83	0.48	0.08
Interest	0.97	0.99	1.15	0.65	0.76	1.04	0.71	1.89	0.65	0.91	0.96	0.86	0.68	0.62	0.77	0.56	0.49	0.3	0.04
Depreciation	1.83	1.86	1.8	0.49	2.21	2.61	1.77	1.77	1.8	1.82	1.69	1.62	1.6	1.62	1.53	1.52	1.57	1.35	1.33
Profit before tax	2.11	2.68	2.13	2.48	3.88	1.95	1.56	2.66	3.28	2.47	4.68	4.36	4.22	4.14	4.32	3.22	5.07	5.05	4.75
Tax %	22.27	21.27	24.88	25.4	24.74	53.85	48.72	22.93	38.11	39.68	15.81	13.53	10.66	13.04	17.13	14.6	25.64	16.44	12.42
Net Profit	1.64	2.12	1.6	1.85	2.92	0.91	0.8	2.04	2.03	1.47	3.95	3.77	3.77	3.6	3.59	2.75	3.78	4.22	4.15
EPS in Rs	1.61	1.97	1.59	1.89	2.73	1.15	1.06	1.68	1.9	1.19	3.3	3.07	2.97	2.85	2.94	2.25	3.09	3.45	3.4

Profit and Loss

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Sales	163	179	141	115	113	125	123
Expenses	148	156	117	91	93	106	105
Operating Profit	14	24	24	24	20	20	17
OPM %	9	13	17	21	17	16	14
Other Income	6	2	2	2	1	2	4
Interest	4	6	3	2	2	1	1
Depreciation	7	7	6	6	3	2	2
Profit before tax	10	13	17	18	16	18	18
Tax %	34	27	14	18	26	26	31
Net Profit	7	9	15	15	12	13	12
EPS in Rs	5.59	8.6	11.73	12.2	9.93	10.88	10.28
Dividend Payout %	18	12	9	8	10	5	10

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash from Operating Activity	-8	-7	-6	4	13	13	4
Cash from Investing Activity	-1	-6	-6	-8	-18	-37	-15
Cash from Financing Activity	-1	6	29	4	6	19	-4
Net Cash Flow	-11	-6	17	0	1	-5	-14

Balance Sheet

	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Equity Capital	14	13	13	13	13	12	12	12	12
Reserves	262	200	203	194	181	134	121	109	75
Borrowings	39	34	20	31	26	26	19	11	12
Other Liabilities	53	50	52	56	59	53	42	49	38
Total Liabilities	367	297	289	295	279	226	194	181	137
Fixed Assets	86	87	89	92	93	92	90	34	24
CWIP	0	0	0	0	0	0	0	40	15
Investments	8	0	0	0	0	0	0	0	0
Other Assets	273	210	200	203	186	133	104	107	97
Total Assets	367	297	289	295	279	226	194	181	137

Delivery

#	Date	217 39% 301	Value (Cr)	Q/T 44	Del 51	Del 1
1	27-May	285	2	73	66	1
2	26-May	272	0	21	76	0
3	25-May	271	0	25	50	0
4	22-May	270	0	26	66	0
5	21-May	267	0	24	54	0
6	20-May	274	0	32	76	0
7	19-May	269	0	24	73	0
8	18-May	269	0	20	60	0
9	15-May	277	0	30	66	0
10	14-May	272	1	19	39	0
11	13-May	278	1	15	26	0
12	12-May	278	0	29	59	0
13	11-May	292	1	39	69	0
14	8-May	294	0	23	63	0
15	7-May	294	1	24	67	0
16	6-May	291	1	41	56	1
17	5-May	281	2	30	42	1
18	4-May	258	0	24	60	0
19	30-Apr	255	0	29	58	0
20	29-Apr	249	0	22	49	0
21	28-Apr	248	0	29	54	0
22	27-Apr	252	1	20	52	1
23	24-Apr	258	1	26	75	0
24	23-Apr	259	1	30	63	0
25	22-Apr	268	0	30	60	0
26	21-Apr	261	1	30	68	0
27	20-Apr	268	1	26	47	1
28	17-Apr	258	1	32	57	0
29	16-Apr	249	1	31	53	0
30	15-Apr	248	1	25	53	0
31	13-Apr	241	1	25	33	0
32	10-Apr	241	1	36	64	1
33	9-Apr	237	0	15	47	0
34	8-Apr	241	1	27	51	1
35	7-Apr	226	1	30	69	1
36	6-Apr	226	1	33	65	1
37	2-Apr	229	2	48	63	1
38	1-Apr	232	1	35	59	1
39	30-Mar	223	3	46	60	2
40	27-Mar	239	3	27	52	1
41	25-Mar	251	2	48	69	1
42	24-Mar	242	1	38	73	1
43	23-Mar	240	2	30	57	1
44	20-Mar	254	1	26	61	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
28-May	388c	12c	3.21
27-May	376c	5c	1.41
26-May	371c	7c	1.88
25-May	364c	2c	0.43
22-May	362c	11c	2.84
21-May	373c	3c	0.90
20-May	370c	6c	1.70
19-May	364c	2c	0.56
18-May	366c	11c	2.88
15-May	376c	10c	2.74
14-May	366c	6c	1.60
13-May	372c	11c	2.97
12-May	384c	16c	3.87
11-May	399c	4c	1.12
07-May	395c	14c	3.58
06-May	381c	47L	0.12
05-May	382c	34c	9.90
04-May	347c	5c	1.39
30-Apr	343c	6c	1.69
29-Apr	337c	6c	1.66
28-Apr	342c	6c	1.80
24-Apr	349c	12c	3.27
23-Apr	361c	6c	1.52
22-Apr	366c	11c	3.02
21-Apr	355c	4c	1.10
20-Apr	359c	7c	1.89
17-Apr	353c	18c	5.49
16-Apr	334c	8c	2.20
15-Apr	342c	0	0

Stock Checklist

Price is below from 52 week high low average: 52%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView